Clinical Trials
5 trialsNCT01409161 2026-05-20
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06678048 2025-06-06
Arsenous Acid for Refractory Triple-Negative Breast Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT01014546 2022-07-22
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis
Roswell Park Cancer Institute
Phase 1 Terminated
NCT02699723 2020-10-22
Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Stanford University
Phase EARLY_PHASE1 Withdrawn
NCT00571116 2019-08-07
Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
University of California, Irvine
Phase 1 Terminated